InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - Liver disease - Islet Biology - Oncology & Immunology
Looking for a particular InSphero employee's phone or email?
InSphero Questions
The InSphero annual revenue was $20.6 million in 2026.
James Evans is the CEO of InSphero.
71 people are employed at InSphero.
The NAICS codes for InSphero are [325, 3254, 54, 32, 32541, 541].
The SIC codes for InSphero are [873, 87].
Top InSphero Employees
-
James Evans
Chief Executive Officer at InSphero
San Diego, CA, US25+ -
Olivier Frey
COO and CTO at InSphero
Schlieren, ZH, CH11 -
Jürg Gysi
Chairman Board of Directors at InSphero
Zürich, ZH, CH3 -
Paul Edgard Clémençon
Chief Business Officer at InSphero
Zürich, ZH, CH23 -
24
-
21
-
Bruno Filippi
Vice President, Liver Safety at InSphero
Zürich, ZH, CH2 -
Madhu Nag
Chief Scientific Officer at InSphero
Washington, DC, US35 -
2
Related Companies
